Platinum-montaur Life Sciences, Llc - Net Worth and Insider Trading
Platinum-montaur Life Sciences, Llc Net Worth
The estimated net worth of Platinum-montaur Life Sciences, Llc is at least $340 dollars as of 2024-09-20. Platinum-montaur Life Sciences, Llc is the 10% Owner of Navidea Biopharmaceuticals Inc and owns about 340,051 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $340. Details can be seen in Platinum-montaur Life Sciences, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Platinum-montaur Life Sciences, Llc has not made any transactions after 2012-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Platinum-montaur Life Sciences, Llc
Platinum-montaur Life Sciences, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Platinum-montaur Life Sciences, Llc owns 3 companies in total, including Echo Therapeutics Inc (ECTE) , Navidea Biopharmaceuticals Inc (NAVB) , and Dais Corp (DLYT) .
Insider Ownership Summary of Platinum-montaur Life Sciences, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ECTE | Echo Therapeutics Inc | 2014-12-18 | 10 percent owner |
| NAVB | Navidea Biopharmaceuticals Inc | 2012-09-21 | 10 percent owner |
| DLYT | Dais Corp | 2009-01-09 | 10 percent owner |
Platinum-montaur Life Sciences, Llc Latest Holdings Summary
Platinum-montaur Life Sciences, Llc currently owns a total of 1 stock. Platinum-montaur Life Sciences, Llc owns 340,051 shares of Navidea Biopharmaceuticals Inc (NAVB) as of September 21, 2012, with a value of $340.
Latest Holdings of Platinum-montaur Life Sciences, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2012-09-21 | 340,051 | 0.00 | 340 |
Holding Weightings of Platinum-montaur Life Sciences, Llc
Platinum-montaur Life Sciences, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Platinum-montaur Life Sciences, Llc has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the sale of 35,419 shares on September 21, 2012, which brought Platinum-montaur Life Sciences, Llc around $3 Million.
Insider Trading History of Platinum-montaur Life Sciences, Llc
- 1
Platinum-montaur Life Sciences, Llc Trading Performance
Platinum-montaur Life Sciences, Llc Ownership Network
Platinum-montaur Life Sciences, Llc Owned Company Details
What does Echo Therapeutics Inc do?
Who are the key executives at Echo Therapeutics Inc?
Platinum-montaur Life Sciences, Llc is the 10 percent owner of Echo Therapeutics Inc. Other key executives at Echo Therapeutics Inc include 10 percent owner Uri Landesman , 10 percent owner Platinum Partners Value Arbitrage Fund, Lp , and 10 percent owner Mark Nordlicht .
Echo Therapeutics Inc (ECTE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Echo Therapeutics Inc (ECTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Therapeutics Inc (ECTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Echo Therapeutics Inc (ECTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Echo Therapeutics Inc Insider Transactions
Platinum-montaur Life Sciences, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Platinum-montaur Life Sciences, Llc. You might contact Platinum-montaur Life Sciences, Llc via mailing address: 152 West 57th Street, 4th Floor, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
